Loxias Technologies Pty Ltd v Curacel International Pty Ltd

Link copied
Case Copied 13 min read

FEDERAL COURT OF AUSTRALIA

Loxias Technologies Pty Ltd v Curacel International Pty Ltd [2002] FCA 1473

Breen v Williams (1996) 186 CLR 71 cited
Johnson Tiles Pty Ltd v Esso Australia Ltd (2000) 104 FCR 564 referred to

LOXIAS TECHNOLOGIES PTY LTD & CURATHERAPY DISTRIBUTION PTY LTD v CURACEL INTERNATIONAL PTY LTD & BILL ELLIOT CHAM

N 166 of 2001

MOORE J
28 NOVEMBER 2002
ADELAIDE (VIA E-COURT)


IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

N 166 OF 2001

BETWEEN:

LOXIAS TECHNOLOGIES PTY LTD
FIRST APPLICANT

CURATHERAPY DISTRIBUTION PTY LTD
SECOND APPLICANT

AND:

CURACEL INTERNATIONAL PTY LTD
FIRST RESPONDENT

BILL ELLIOT CHAM
SECOND RESPONDENT

JUDGE:

MOORE J

DATE OF ORDER:

28 NOVEMBER 2002

WHERE MADE:

ADELAIDE (VIA E-COURT)

THE COURT ORDERS THAT:

1.Paragraphs 56, 57 and 58 of the Statement of Claim be struck out.

2.Paragraphs 3.4.2, 8.1, 8.2.2, 8.4.2, 8.4.6, 12, 13.2, 13.3, 18.3, 19.4, 21.1, 26.1, 27.2, 29.4, 30, 32.5, 32.7, 37.1 and 37.2 of the Defence be struck out.

3.The respondents file and serve an amended defence within 14 days from the date of this judgment.

4.General discovery is to be given by each party filing and serving a list of documents within 28 days from the date of this judgment.

5.Inspection of discovered documents is to take place before 30 January 2003.

6.The matter be listed for directions at 9.30 am on 3 February 2003.

7.Costs are reserved.

8.Liberty to apply.

Note:    Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.


IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

N 166 OF 2001

BETWEEN:

LOXIAS TECHNOLOGIES PTY LTD
FIRST APPLICANT

CURATHERAPY DISTRIBUTION PTY LTD
SECOND APPLICANT

AND:

CURACEL INTERNATIONAL PTY LTD
FIRST RESPONDENT

BILL ELLIOT CHAM
SECOND RESPONDENT

JUDGE:

MOORE J

DATE:

28 NOVEMBER 2002

PLACE:

ADELAIDE (VIA E-COURT)

REASONS FOR JUDGMENT

  1. There remains an issue about the pleadings in this matter.  In an earlier judgment concerning an earlier version of the statement of claim, the history of the matter was set out in some detail: see Loxias Technologies Pty Ltd v International Pty Ltd [2002] FCA 753.  I will not repeat what was said in that judgment concerning the background, the history of the proceedings in the Court and generally the claims made by the first applicant Loxias Technologies Pty Ltd (“Loxias”) and the second applicant Curatherapy Distribution Pty Ltd (“Curatherapy”) against the first respondent Curacel International Pty Limited (“Curacel”) and the second respondent Mr Bill Cham (“Cham”). 

  2. There remains an issue about two aspects of the statement of claim.  The first is a claim against Cham which, while initially said to involve a breach of a common law duty as a director of Loxias, is now put as a breach of a fiduciary duty as a director.  This duty would be reflected in paragraphs 56, 57 and 58 of the fifth further amended statement of claim (filed pursuant to orders made 14 June 2002) on the basis that, if…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Loxias Technologies Pty Ltd v Curacel International Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2002] FCA 1473
Decision Date

CaseChat Overview and Summary

Loxias Technologies Pty Ltd sought relief against Curacel International Pty Ltd in the Federal Court of Australia over disputes involving alleged breaches of contract and intellectual property infringement. The case centred on claims of wrongful use of patented technology and breaches of confidentiality, with Loxias asserting that Curacel had misused their patented processes and divulged sensitive information.

The legal issues before the court encompassed the validity of the claims made by Loxias regarding the misuse of their patented technology and the confidentiality obligations breached by Curacel. Furthermore, the court had to determine the admissibility of certain evidence and the necessity for specific paragraphs in the pleadings.

In its judgment, the court ruled that several paragraphs in both the Statement of Claim and the Defence were either irrelevant or redundant and thus struck them out. It found that these paragraphs did not contribute to the core issues of the case and were likely to mislead the proceedings. The court mandated that Curacel file an amended Defence within a stipulated timeframe and directed both parties to provide comprehensive lists of documents for discovery. Additionally, the court set a date for the inspection of these documents and scheduled a directions hearing to manage the progression of the case. The court reserved the decision on costs and allowed for potential future applications regarding the matter.

Orders

Orders of the court

1. Paragraphs 56, 57 and 58 of the Statement of Claim be struck out.

2. Paragraphs 3.4.2, 8.1, 8.2.2, 8.4.2, 8.4.6, 12, 13.2, 13.3, 18.3, 19.4, 21.1, 26.1, 27.2, 29.4, 30, 32.5, 32.7, 37.1 and 37.2 of the Defence be struck out.

3. The respondents file and serve an amended defence within 14 days from the date of this judgment.

4. General discovery is to be given by each party filing and serving a list of documents within 28 days from the date of this judgment.

5. Inspection of discovered documents is to take place before 30 January 2003.

6. The matter be listed for directions at 9.30 am on 3 February 2003.

7. Costs are reserved.

8. Liberty to apply.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

MOORE J

Ratio Decidendi

Legal Principle Established

Established by: MOORE J